These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 28638844)

  • 21. Cost-utility analysis of outpatient parenteral antimicrobial therapy (OPAT) in the Brazilian national health system.
    Psaltikidis EM; Silva END; Moretti ML; Trabasso P; Stucchi RSB; Aoki FH; Cardoso LGO; Höfling CC; Bachur LF; Ponchet DDF; Colombrini MRC; Tozzi CS; Ramos RF; Costa SMQ; Resende MR
    Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):341-352. PubMed ID: 30362845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the utilization and impact of a newly established outpatient parenteral antimicrobial therapy (OPAT) program.
    Yan M; Lam PW; Andany N; Chan AK; Leis JA; Mubareka S; Simor AE; Daneman N
    J Assoc Med Microbiol Infect Dis Can; 2020 Jun; 5(2):70-76. PubMed ID: 36338181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use, appropriateness and outcomes of outpatient parenteral antimicrobial therapy.
    Hodgson KA; Huynh J; Ibrahim LF; Sacks B; Golshevsky D; Layley M; Spagnolo M; Raymundo CM; Bryant PA
    Arch Dis Child; 2016 Oct; 101(10):886-93. PubMed ID: 27166221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective analysis of outcomes of outpatient parenteral antimicrobial therapy (OPAT) for necrotising otitis externa.
    Durojaiye OC; Slucka A; Kritsotakis EI
    Eur J Clin Microbiol Infect Dis; 2022 Jun; 41(6):941-949. PubMed ID: 35556187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of a multidisciplinary team review of potential outpatient parenteral antimicrobial therapy prior to discharge from an academic medical center.
    Heintz BH; Halilovic J; Christensen CL
    Ann Pharmacother; 2011 Nov; 45(11):1329-37. PubMed ID: 21990938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outpatient Parenteral Antimicrobial Therapy in Pediatric Medicaid Enrollees.
    Goldman JL; Richardson T; Newland JG; Lee B; Gerber JS; Hall M; Kronman M; Hersh AL
    J Pediatric Infect Dis Soc; 2017 Mar; 6(1):65-71. PubMed ID: 26803327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years.
    Barr DA; Semple L; Seaton RA
    Int J Antimicrob Agents; 2012 May; 39(5):407-13. PubMed ID: 22445493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experiences in outpatient parenteral antimicrobial therapy (OPAT): Barriers and challenges from the front lines.
    Ng N; Bailey P; Pryor R; Fung L; Veals C; Sabouri K; Reznicek J
    Antimicrob Steward Healthc Epidemiol; 2021; 1(1):e42. PubMed ID: 36168502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving the safety of outpatient parenteral antimicrobial therapy for patients with solid tumors.
    Robins A; Dishner E; McDaneld P; Rowan M; Bartek J; Jiang Y; Adachi J; Dailey Garnes NJM
    Support Care Cancer; 2022 Feb; 30(2):1643-1654. PubMed ID: 34550460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetic Foot Infection and Select Comorbidities Drive Readmissions in Outpatient Parenteral Antimicrobial Therapy.
    Barnes A; Nunez M
    Am J Med Sci; 2021 Feb; 361(2):233-237. PubMed ID: 33097196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outpatient parenteral antimicrobial therapy with continuous infusion of meropenem: A retrospective analysis of three years of clinical experience.
    Dubois-Silva Á; Otero-Plaza L; Dopico-Santamariña L; Mozo-Ríos A; Hermida-Porto L; Feal-Cortizas B; García-Queiruga M; Pértega-Díaz S; Lamelo-Alfonsín F; Vidán-Martínez L
    Enferm Infecc Microbiol Clin (Engl Ed); 2023; 41(6):321-328. PubMed ID: 36610829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Impact of an Infectious Diseases Transition Service on the Care of Outpatients on Parenteral Antimicrobial Therapy.
    Keller SC; Ciuffetelli D; Bilker W; Norris A; Timko D; Rosen A; Myers JS; Hines J; Metlay J
    J Pharm Technol; 2013 Oct; 29(5):205-214. PubMed ID: 25621307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-administered outpatient parenteral antimicrobial therapy (S-OPAT) for infective endocarditis: a safe and effective model.
    Pajarón M; Fernández-Miera MF; Allende I; Arnaiz AM; Gutiérrez-Cuadra M; Cobo-Belaustegui M; Armiñanzas C; de Berrazueta JR; Fariñas MC; Sanroma P;
    Eur J Intern Med; 2015 Mar; 26(2):131-6. PubMed ID: 25596808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective.
    Wai AO; Frighetto L; Marra CA; Chan E; Jewesson PJ
    Pharmacoeconomics; 2000 Nov; 18(5):451-7. PubMed ID: 11151398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of outpatient parenteral antimicrobial therapy (OPAT) for patients with cranial infection.
    Kilinc F; Setzer M; Behmanesh B; Jussen D; Gessler F; Bayerl S; Kempf VAJ; Kessel J; Czabanka M; Prinz V
    Front Med (Lausanne); 2023; 10():1202969. PubMed ID: 37942421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outpatient parenteral antimicrobial therapy and antibiotic stewardship: opponents or teammates?
    Steffens E; Quintens C; Derdelinckx I; Peetermans WE; Van Eldere J; Spriet I; Schuermans A
    Infection; 2019 Apr; 47(2):169-181. PubMed ID: 30443780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes According to Discharge Location for Persons Who Inject Drugs Receiving Outpatient Parenteral Antimicrobial Therapy.
    D'Couto HT; Robbins GK; Ard KL; Wakeman SE; Alves J; Nelson SB
    Open Forum Infect Dis; 2018 May; 5(5):ofy056. PubMed ID: 29766017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic Burden of Home Antimicrobial Therapy: OPAT Versus Oral Therapy.
    Krah NM; Bardsley T; Nelson R; Esquibel L; Crosby M; Byington CL; Pavia AT; Hersh AL
    Hosp Pediatr; 2019 Apr; 9(4):234-240. PubMed ID: 30885919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years.
    Matthews PC; Conlon CP; Berendt AR; Kayley J; Jefferies L; Atkins BL; Byren I
    J Antimicrob Chemother; 2007 Aug; 60(2):356-62. PubMed ID: 17566002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A single centre experience of prosthetic joint infection outcomes with outpatient parenteral antimicrobial therapy.
    Kutubi A; O'Brien L; Murphy B; Fitzpatrick P; Hurson C; Rajendran D; Feeney E; Mallon P; Waqas S
    Heliyon; 2023 Apr; 9(4):e15212. PubMed ID: 37113779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.